Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3243 | 2030 | 50.2 | 95% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
27 | 3 | DEVELOPMENTAL BIOLOGY//DEVELOPMENT//AGR2 | 109777 |
2542 | 2 | CADASIL//NOTCH3//NOTCH | 3755 |
3243 | 1 | NOTCH1//NOTCH//GAMMA SECRETASE INHIBITOR | 2030 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NOTCH1 | authKW | 1204750 | 11% | 35% | 231 |
2 | NOTCH | authKW | 777374 | 20% | 13% | 398 |
3 | GAMMA SECRETASE INHIBITOR | authKW | 507806 | 4% | 41% | 83 |
4 | NOTCH SIGNALING | authKW | 394404 | 7% | 19% | 140 |
5 | JAGGED1 | authKW | 221118 | 3% | 28% | 53 |
6 | NOTCH3 | authKW | 180466 | 3% | 23% | 53 |
7 | NOTCH INHIBITOR | authKW | 133771 | 1% | 68% | 13 |
8 | RO4929097 | authKW | 121824 | 0% | 90% | 9 |
9 | NOTCH SIGNALING PATHWAY | authKW | 113340 | 1% | 27% | 28 |
10 | NOTCH LIGANDS | authKW | 104044 | 1% | 43% | 16 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 12687 | 41% | 0% | 838 |
2 | Cell Biology | 3887 | 24% | 0% | 478 |
3 | Hematology | 2352 | 11% | 0% | 224 |
4 | Immunology | 1708 | 15% | 0% | 312 |
5 | Medicine, Research & Experimental | 735 | 8% | 0% | 166 |
6 | Pathology | 494 | 5% | 0% | 103 |
7 | Cell & Tissue Engineering | 458 | 1% | 0% | 30 |
8 | Biochemistry & Molecular Biology | 383 | 16% | 0% | 319 |
9 | Developmental Biology | 189 | 2% | 0% | 47 |
10 | Genetics & Heredity | 136 | 5% | 0% | 99 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MED GENET DEV BIOL | 58669 | 1% | 18% | 22 |
2 | FDN CA GRANDA IRCCS POLICLIN | 33839 | 0% | 75% | 3 |
3 | PROGRAM STEM CELL DEV BIOL | 33839 | 0% | 75% | 3 |
4 | CARDINAL BERNARDIN CANC | 31024 | 1% | 7% | 29 |
5 | KARL LANDSTEINER CYTOKINE TUMOUR MICROENVI | 30081 | 0% | 100% | 2 |
6 | ABRAMSON FAMILY CANC | 25146 | 2% | 3% | 48 |
7 | RADIOTHER Y MAASTRO GROW | 22557 | 0% | 50% | 3 |
8 | IMMUNOL PARASITOL | 22328 | 1% | 7% | 20 |
9 | LAUSANNE BRANCH | 20581 | 1% | 6% | 24 |
10 | USTER TRANSPLANTAT | 20052 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IMMUNITY | 3643 | 1% | 1% | 29 |
2 | BLOOD | 3193 | 4% | 0% | 87 |
3 | ONCOTARGET | 2199 | 2% | 0% | 43 |
4 | CANCER CELL | 2188 | 1% | 1% | 15 |
5 | ONCOLOGY REPORTS | 2017 | 2% | 0% | 37 |
6 | ONCOGENE | 2004 | 2% | 0% | 50 |
7 | CANCER RESEARCH | 2001 | 4% | 0% | 74 |
8 | JOURNAL OF IMMUNOLOGY | 1468 | 4% | 0% | 75 |
9 | LEUKEMIA | 1407 | 1% | 0% | 27 |
10 | ONCOLOGY LETTERS | 1301 | 1% | 0% | 22 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NOTCH1 | 1204750 | 11% | 35% | 231 | Search NOTCH1 | Search NOTCH1 |
2 | NOTCH | 777374 | 20% | 13% | 398 | Search NOTCH | Search NOTCH |
3 | GAMMA SECRETASE INHIBITOR | 507806 | 4% | 41% | 83 | Search GAMMA+SECRETASE+INHIBITOR | Search GAMMA+SECRETASE+INHIBITOR |
4 | NOTCH SIGNALING | 394404 | 7% | 19% | 140 | Search NOTCH+SIGNALING | Search NOTCH+SIGNALING |
5 | JAGGED1 | 221118 | 3% | 28% | 53 | Search JAGGED1 | Search JAGGED1 |
6 | NOTCH3 | 180466 | 3% | 23% | 53 | Search NOTCH3 | Search NOTCH3 |
7 | NOTCH INHIBITOR | 133771 | 1% | 68% | 13 | Search NOTCH+INHIBITOR | Search NOTCH+INHIBITOR |
8 | RO4929097 | 121824 | 0% | 90% | 9 | Search RO4929097 | Search RO4929097 |
9 | NOTCH SIGNALING PATHWAY | 113340 | 1% | 27% | 28 | Search NOTCH+SIGNALING+PATHWAY | Search NOTCH+SIGNALING+PATHWAY |
10 | NOTCH LIGANDS | 104044 | 1% | 43% | 16 | Search NOTCH+LIGANDS | Search NOTCH+LIGANDS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LEONG, KG , KARSAN, A , (2006) RECENT INSIGHTS INTO THE ROLE OF NOTCH SIGNALING IN TUMORIGENESIS.BLOOD. VOL. 107. ISSUE 6. P. 2223-2233 | 96 | 69% | 296 |
2 | RADTKE, F , FASNACHT, N , MACDONALD, HR , (2010) NOTCH SIGNALING IN THE IMMUNE SYSTEM.IMMUNITY. VOL. 32. ISSUE 1. P. 14-27 | 80 | 65% | 198 |
3 | SHANG, YL , SMITH, S , HU, XY , (2016) ROLE OF NOTCH SIGNALING IN REGULATING INNATE IMMUNITY AND INFLAMMATION IN HEALTH AND DISEASE.PROTEIN & CELL. VOL. 7. ISSUE 3. P. 159 -174 | 80 | 68% | 3 |
4 | NTZIACHRISTOS, P , LIM, JS , SAGE, J , AIFANTIS, I , (2014) FROM FLY WINGS TO TARGETED CANCER THERAPIES: A CENTENNIAL FOR NOTCH SIGNALING.CANCER CELL. VOL. 25. ISSUE 3. P. 318 -334 | 96 | 44% | 83 |
5 | ESPINOZA, I , MIELE, L , (2013) NOTCH INHIBITORS FOR CANCER TREATMENT.PHARMACOLOGY & THERAPEUTICS. VOL. 139. ISSUE 2. P. 95-110 | 113 | 45% | 63 |
6 | HUANG, TT , ZHOU, YH , CHENG, ASL , YU, J , TO, KF , KANG, W , (2016) NOTCH RECEPTORS IN GASTRIC AND OTHER GASTROINTESTINAL CANCERS: ONCOGENES OR TUMOR SUPPRESSORS?.MOLECULAR CANCER. VOL. 15. ISSUE . P. - | 97 | 65% | 0 |
7 | SANDY, AR , MAILLARD, I , (2009) NOTCH SIGNALING IN THE HEMATOPOIETIC SYSTEM.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 9. ISSUE 11. P. 1383 -1398 | 101 | 68% | 28 |
8 | GU, YS , MASIERO, M , BANHAM, AH , (2016) NOTCH SIGNALING: ITS ROLES AND THERAPEUTIC POTENTIAL IN HEMATOLOGICAL MALIGNANCIES.ONCOTARGET. VOL. 7. ISSUE 20. P. 29804 -29823 | 87 | 58% | 3 |
9 | YUAN, X , WU, H , XU, HX , XIONG, HH , CHU, Q , YU, SY , WU, GS , WU, KM , (2015) NOTCH SIGNALING: AN EMERGING THERAPEUTIC TARGET FOR CANCER TREATMENT.CANCER LETTERS. VOL. 369. ISSUE 1. P. 20 -27 | 63 | 74% | 15 |
10 | OLSAUSKAS-KUPRYS, R , ZLOBIN, A , OSIPO, C , (2013) GAMMA SECRETASE INHIBITORS OF NOTCH SIGNALING.ONCOTARGETS AND THERAPY. VOL. 6. ISSUE . P. 943 -955 | 78 | 62% | 35 |
Classes with closest relation at Level 1 |